Submandibular Gland Excision: 10-Year OutcomeMehmet Yilmaz1*, Ferit Akil1, Haydar Murat Yener1, Faruk Aydin1, Gül Özbilen Acar2 and Özgün Enver1
- Corresponding Author:
- Dr. Mehmet Yilmaz
Department of Otorhinolaryngology
Cerrahpasa Medical Faculty
Istanbul University, Turkey
E-mail: [email protected]
Received date: July 18, 2013; Accepted date: July 23, 2013; Published date: July 30, 2013
Citation: Yilmaz M, Akil F, Yener HM, Aydin F, Acar GÃ–, et al. (2013) Submandibular Gland Excision: 10-Year Outcome. Otolaryngology 3:138. doi:10.4172/2161-119X.1000138
Copyright: © 2013 Yilmaz M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Background: Submandibular gland is the second largest salivary gland in human body. There are neoplastic and non-neoplastic diseases affecting the gland, while sialolithiasis is the most common non-neoplastic disease, pleomorphic adenoma is the most common neoplastic disease of the gland. The most common malignant tumor is adenoid cystic carcinoma.
Material and method: Patients who underwent submandibular gland operation at Cerrahpasa Medical School between 2002 and 2012 were retrospectively analyzed.
Results: Of the patients, 40 were male and 50 were female. Neoplastic diseases were seen in 42 patients and non-neoplastic diseases were seen in 48. The most common neoplastic benign tumor was pleomorphic adenoma, and the most common malignant tumor was mucoepidermoid carcinoma. The most common non-neoplastic disease was sialolithiasis followed by sialadenitis.
Conclusion: While data were consistent with the literature in general, mucoepidermoid carcinoma was found to be the most common malignant tumor of submandibular gland, which was different from the literature.